{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:28:05Z","timestamp":1761560885836},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.dld.2004.01.019","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:53:24Z","timestamp":1082714004000},"page":"384-387","source":"Crossref","is-referenced-by-count":15,"title":["Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States"],"prefix":"10.1016","volume":"36","author":[{"given":"D.Y.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Belson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Abudayyeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Osato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.T.","family":"El-Zimaity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2004.01.019_BIB1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection\u2014the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment. Pharmacol Ther."},{"key":"10.1016\/j.dld.2004.01.019_BIB2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2036.2000.00767.x","article-title":"The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group","volume":"14","author":"Moayyedi","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2004.01.019_BIB3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1046\/j.1365-2036.2002.01244.x","article-title":"Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy","volume":"16","author":"Della Monica","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2004.01.019_BIB4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.2003.01566.x","article-title":"Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis","volume":"17","author":"Gene","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2004.01.019_BIB5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0016-5085(98)70100-3","article-title":"Antibiotic resistance in Helicobacter pylori: implications for therapy","volume":"115","author":"Graham","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.01.019_BIB6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0016-5085(00)70003-5","article-title":"Therapy of Helicobacter pylori: current status and issues","volume":"118","author":"Graham","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.01.019_BIB7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2036.1997.00219.x","article-title":"Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection","volume":"11","author":"Graham","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2004.01.019_BIB8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1572-0241.2002.05600.x","article-title":"Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection","volume":"97","author":"Dore","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2004.01.019_BIB9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-5378.2003.00150.x","article-title":"Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen","volume":"8","author":"Dore","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2004.01.019_BIB10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0046-8177(99)90303-9","article-title":"Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System","volume":"30","author":"El-Zimaity","year":"1999","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.dld.2004.01.019_BIB11","first-page":"1962","article-title":"Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test","volume":"90","author":"El-Zimaity","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2004.01.019_BIB12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0046-8177(94)90191-0","article-title":"Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain","volume":"25","author":"Genta","year":"1994","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.dld.2004.01.019_BIB13","first-page":"732","article-title":"A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin\/Alcian blue\/hematoxylin\u2013eosin","volume":"122","author":"El-Zimaity","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.dld.2004.01.019_BIB14","first-page":"641","article-title":"Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens","volume":"8","author":"de Boer","year":"1996","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.dld.2004.01.019_BIB15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0010-4825(96)00006-6","article-title":"Quickbasic program for exact and mid-P confidence intervals for a binomial proportion","volume":"26","author":"Fagan","year":"1996","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.dld.2004.01.019_BIB16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2174\/1381612003399059","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori: sensitivity test results and their clinical relevance","volume":"6","author":"Osato","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.dld.2004.01.019_BIB17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(00)00320-4","article-title":"Comparison of the E-test and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori","volume":"17","author":"Osato","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.dld.2004.01.019_BIB18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.161.9.1217","article-title":"Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States","volume":"161","author":"Osato","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.dld.2004.01.019_BIB19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(95)92962-2","article-title":"Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection","volume":"345","author":"de Boer","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2004.01.019_BIB20","first-page":"1993","article-title":"Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori","volume":"89","author":"de Boer","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2004.01.019_BIB21","first-page":"1381","article-title":"90% cure: which anti-Helicobacter therapy can achieve this treatment goal?","volume":"90","author":"de Boer","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2004.01.019_BIB22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004836-199606000-00016","article-title":"How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients. A personal viewpoint","volume":"22","author":"de Boer","year":"1996","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.dld.2004.01.019_BIB23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1523-5378.1996.tb00028.x","article-title":"Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection","volume":"1","author":"de Boer","year":"1996","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2004.01.019_BIB24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00042737-199907000-00002","article-title":"Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection","volume":"11","author":"de Boer","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.dld.2004.01.019_BIB25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/gast.2002.37051","article-title":"A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE Study","volume":"123","author":"Katelaris","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.01.019_BIB26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study","volume":"14","author":"Graham","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2004.01.019_BIB27","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0002-9270(99)00258-0","article-title":"The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis","volume":"94","author":"van der Wouden","year":"1999","journal-title":"Am. J. Gastroenterol."}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1590865804000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1590865804000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T06:18:56Z","timestamp":1497593936000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865804000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1590865804000854"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2004.01.019","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}